Home > Journals > Giornale Italiano di Dermatologia e Venereologia > Past Issues > Giornale Italiano di Dermatologia e Venereologia 2005 October;140(5) > Giornale Italiano di Dermatologia e Venereologia 2005 October;140(5):569-73

CURRENT ISSUE
 

ARTICLE TOOLS

Reprints

GIORNALE ITALIANO DI DERMATOLOGIA E VENEREOLOGIA

A Journal on Dermatology and Sexually Transmitted Diseases


Official Journal of the Italian Society of Dermatology and Sexually Transmitted Diseases
Indexed/Abstracted in: EMBASE, PubMed/MEDLINE, Science Citation Index Expanded (SciSearch), Scopus
Impact Factor 1,311


eTOC

 

CLINICAL CASES  


Giornale Italiano di Dermatologia e Venereologia 2005 October;140(5):569-73

Copyright © 2005 EDIZIONI MINERVA MEDICA

language: English, Italian

The use of Imiquimod 5% cream for the treatment of basal cell carcinomas in a Gorlin’s syndrome

Di Landro A., Naldi L., Marchesi L.

Department of Dermatology, University of Milano-Bicocca Ospedali Riuniti, Bergamo, Italy


PDF  


Imiquimod 5% cream has been used effectively to treat basal cell carcinomas (BCCs). The purpose of this study was to examine the effectiveness and tolerability of Imiquimod 5% cream in treating superficial non-facial BCCs in a patient with basal cell nevus syndrome or Gorlin's syndrome and to follow the patient over time for any signs of relapse. Five superficial BCCs in the mammarian region of a woman suffering psychologically due to multiple scars resulting from many BCC removals, were treated for 18 weeks with a once-a-day application of Imiquimod 5% cream. A biopsy was performed before and after the treatment. The 5 BCCs regressed completely without any sign of histological persistence. Topical therapy caused irritation in the first weeks of treatment, which resolved after a reduction in the number of applications. A three-year follow up confirmed that no relapse had occurred and no scarring was present at the sites of treatment; only the appearance of a new small papular lesion was noted slightly above the treated area. Imiquimod 5% cream can be considered an effective treatment with good cosmetic results and absence of long term recurrence for multiple BCCs in basal cell nevus syndrome.

top of page

Publication History

Cite this article as

Corresponding author e-mail